3D Global Biotech Inc. (6808)
Market Closed
16 Jul, 05:30
TWSE TWSE Primary NT$
40. 40
+0.1
+0.2481%
NT$
- Market Cap
- P/E Ratio
0.02% Div Yield
639,089 Volume
0 Eps
NT$ 40.3
Previous Close Want to track 6808 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3D Global Biotech Inc. (6808) Statistics
Valuation metrics
Market Cap -
Enterprise value 3B
Trailing P/E (ttm) 44.83
Forward P/E -
PEG ratio -1.3
Price/Sales (ttm) 14.35
Price/Book (mrq) 3.03
Enterprise Value/Revenue 14.51
Enterprise Value/EBITDA 47.89
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 242.9K
Average volume (90 days) 232.87K
Price summary
52-Week low 22.45
52-Week high 63
Beta -
50-Day moving average 29.2
200-Day moving average 35.84
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.53
Trailing annual dividend yield 0.0137%
5-Year annual dividend yield -
Payout ratio 0.62
Dividend Date 30 Jul 2025
Ex-Dividend Date 7 Jul 2025
Last split factor 1,013:1,000
Last split Date 31 Jul 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.32%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.67
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.17
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 14.08%
Book value per share (mrq) 12.73
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
